Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Chemicals
  4. Organic compounds
  5. Organonitrogen Compounds
  6. Imines
  7. BMS 536924, Tocris Bioscience™

BMS 536924, Tocris Bioscience™

Catalog No. 477410
Click to view available options
Quantity:
10 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Description

Dual IR/IGF1R inhibitor

Dual inhibitor of the insulin receptor (IR) and insulin-like growth factor-1 receptor (IGF1R) (IC50 values are 73 and 100 nM respectively). Inhibits receptor autophosphorylation and downstream MEK1/2 and Akt signaling. Induces G1 arrest and apoptosis in ML-1 cells; also inhibits cell proliferation in multiple tumor types. Reverses EMT through the attenuation of Snail mRNA expression in MCF10A cell over expressing IGF1R.

Chemical Identifiers

CAS 468740-43-4
Molecular Formula C25H26ClN5O3
Molecular Weight (g/mol) 479.965
InChI Key UGQMURPIMYALPH-OAQYLSRUSA-N
Synonym s-4-2-3-chlorophenyl-2-hydroxyethyl amino-3-4-methyl-6-morpholino-1h-benzo d imidazol-2-yl pyridin-2 1h-one, 4-2s-2-3-chlorophenyl-2-hydroxyethyl amino-3-4-methyl-6-morpholin-4-yl-3h-1,3-benzodiazol-2-yl-1h-pyridin-2-one
PubChem CID 68925359
IUPAC Name 4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-(4-methyl-6-morpholin-4-yl-1,3-dihydrobenzimidazol-2-ylidene)pyridin-2-one
SMILES CC1=CC(=CC2=C1NC(=C3C(=CC=NC3=O)NCC(C4=CC(=CC=C4)Cl)O)N2)N5CCOCC5

Specifications

Quantity 10 mg
Formula Weight 479.96
Percent Purity >98%
Chemical Name or Material BMS 536924

Safety and Handling

Recommended Storage Store at -20°C
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.